A randomized controlled study on the effects of the T-REX Twente (Thoracic Surgical Rehabilitation Experts Twente) sternal precautions on quality of life and physical activity levels in cardiac surgery patients, compared to standard care in patients following a median sternotomy: the study protocol Authors: N Wielens, K Roerdink, W Lynch, L Esau, J van der Palen, F R Halfwerk Published: 2026 ABSTRACT AbstractBackgroundIn 2023, a majority (86%) of open-heart surgeries was performed at Thorax Centrum Twente (TCT) via a full median sternotomy. Currently, there is no consensus on postoperative sternal precautions following full median sternotomy. Research from the USA and Canada suggests that existing restrictive sternal precautions may not be necessary. More lenient sternal precautions, such as the “Keep Your Move in the Tube” principle, have shown positive outcomes, with no significant complications. Patients following this approach experienced fewer mobility issues and reported improved quality of life and reduced anxiety. This study explores the potential benefits of fewer restrictions, which could reduce patient anxiety and lead to fewer follow-up visits. This study aims to determine whether the Thoracic Surgical Rehabilitation Experts Twente (T-REX Twente) sternal precautions have a small positive effect on the Modified MacNew Quality of Life after Myocardial Infarction questionnaire (QLMI-2), physical activity, and reduction of movement-related anxiety in patients after full median sternotomy, compared to standard restrictive sternal precautions. It also assesses whether the T-REX sternal precautions result in no negative effects on pain, wound healing, or postoperative complications.MethodsThis prospective, randomized, controlled, single-blind study will include adult patients undergoing full median sternotomy at TCT between June 2024 and June 2026, all participating in outpatient cardiac rehabilitation. Exclusion criteria include intensive care unit stays over 72 h, delirium, dementia, severe cognitive impairments, language barriers, or treatment by an external referring cardiologist. The control group will adhere to current restrictive sternal precautions, whereas those in the intervention group will follow the T-REX sternal precautions, which allow lifting, pushing, or pulling as long as arm movement remains within a defined “tube.” The primary endpoint is the change in QLMI-2 from baseline (T0) to start of phase II cardiac rehabilitation (T4).DiscussionThe T-REX Twente sternal precautions may improve quality of life, physical activity, and reduce movement-related anxiety, supporting the idea that less restrictive postoperative sternal precautions can enhance patient outcomes.Trial registrationCCMO Trial Register NL78107.100.23, registered on 29 February 2024. ClinicalTrials.gov: NCT06115759.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s13063-026-09877-z.Keywords: Health-related quality of life, Modified MacNew Quality of Life after Myocardial Infarction questionnaire (QLMI-2), Sternum, Sternal precautions, Keep Your Move in a Tube (KYMITT), Early mobilization, Thoracic surgery, Restrictions, Regimen Administrative information Note: the numbers in curly brackets in this protocol refer to SPIRIT checklist item numbers. The order of the items has been modified to group similar items (see http://www.equator-network.org/reporting-guidelines/spirit-2013-statement-defining-standard-protocol-items-for-clinical-trials/). Title {1}A randomized controlled study on the effects of the T-REX Twente (Thoracic Surgical Rehabilitation Experts Twente) sternal precautions on quality of life and physical activity levels in cardiac surgery patients, compared to standard care in patients following a median sternotomy: the study protocolTrial registration {2a and 2b}CCMO Trial Register NL78107.100.23 registered on 29 February 2024ClinicalTrials.gov: NCT06115759https://onderzoekmetmensen.nl/en/trial/56700https://clinicaltrials.gov/study/NCT06115759These registries comply to the World Health Organization Trial Registration Data Set recommendationsProtocol version {3}Protocol version 8.4 of 22 February 2024Funding {4}NW’s research time was funded by Heart Prevention East Netherlands (HPON) Foundation. Additionally, accelerometers used in the study were partially sponsored by the Twente Heart Foundation (Stichting Hartcentrum Twente) for the MOVEMENTT study, previously conducted in Thorax Centrum TwenteAuthor details {5a}Conceptualization: NW, KR, LE, FH; methodology: JvdP and FH; validation: JvdP and FH; formal analysis: JvdP and FH; investigation: NW and KR; resources: LE, WL, JvdP, FH; writing—original draft: NW, KR, FH; writing—review and editing: NW, KR, LE, WL, JvdP, FH; visualization: KR and FH; supervision: WL, JvdP, FH; project administration: NW and FH; funding acquisition: NW and FHName and contact information for the trial sponsor {5b}Trial sponsor: Medisch Spectrum Twente, Thorax Centrum Twente, Department of Cardio-thoracic SurgeryContact name: Dr. Frank R. Halfwerk, f.halfwerk@mst.nl Address: Koningsplein 1, 7512 KZ Enschede, the NetherlandsTelephone: +31 (0)53–4786007 or +31 (0)615060570Role of sponsor {5c}For this investigator-initiated clinical trial, the funders played no role in the design of the study, data collection, analysis, and interpretation of data, and in writing the manuscript, nor the decision to publish this work CCMO Trial Register NL78107.100.23 registered on 29 February 2024 ClinicalTrials.gov: NCT06115759 https://onderzoekmetmensen.nl/en/trial/56700 https://clinicaltrials.gov/study/NCT06115759 These registries comply to the World Health Organization Trial Registration Data Set recommendations Trial sponsor: Medisch Spectrum Twente, Thorax Centrum Twente, Department of Cardio-thoracic Surgery Contact name: Dr. Frank R. Halfwerk, f.halfwerk@mst.nl Address: Koningsplein 1, 7512 KZ Enschede, the Netherlands Telephone: +31 (0)53–4786007 or +31 (0)615060570 Introduction Background and rationale {6a} In the Netherlands, almost 10,000 open-heart surgeries are performed annually, with the majority (89%) of these procedures being carried out via median sternotomy in 2023 [1]. In 2023, the Thorax Centrum Twente (TCT) conducted 866 open-heart surgeries, of which 749 (86%) were performed via median sternotomy. There is no global consensus regarding postoperative mobilization precautions following a median sternotomy. Restrictive precautions do not improve sternal outcomes, yet may negatively influence functional recovery [2]. Indeed, less restrictive post-sternotomy protocols were associated with improved functional outcomes and earlier independence in activities of daily living (ADL), without an increase in sternal complications [2]. Moreover, early upper extremity resistance exercise after median sternotomy does not result in clinically relevant sternal micromotion, while strict weightlifting restrictions lack high-quality evidence [3]. These findings suggest that strict movement limitations may unnecessarily reduce weight-bearing activities of the upper limbs, potentially contributing to muscle deconditioning and prolonged ADL dependency following heart surgery. Although early mobilization from post-operative day 1 is recommended as part of the Enhanced Recovery after Cardiac Surgery (ERAS Cardiac) program [4], specifications on how to do so with high levels of evidence are still needed. We conducted a survey within the TCT network to assess current precautionary practices after median sternotomy [5]. On postoperative day 3, significant variations were found in clinical practice regarding sleeping positions, transitioning from a lying to a sitting position, and post-discharge activities such as carrying groceries or vacuuming. The current postoperative sternal precautions at TCT include, among other things, advising against lifting, pushing, or pulling more than 2 kg for the first 6 weeks to protect the sternum (Table 1). Table 1Standard postoperative care following cardiac surgery in Thorax Centrum Twente with lifestyle adviceCoughing/sneezingProtect the wound by crossing the arms over the chestPostoperativelySit up in a chair as soon as possibleGet out of bed using the rope behind the bed and by shifting from side to side (waddling)Stand up by placing hands on the kneesAsymmetrical arm movement without load is allowedLying on the side: allowed if the drain is removed (and pain permits)Day 2: start walkingDay 3: cycling (stationary bike)Before discharge: stair climbing, 11 or 22 stepsHome activity progressionPositive lifestyle guidelines are provided, detailing which activities and movements are allowed or recommended, and what should be avoidedCycling and driving2–3 weeks postoperatively, after the first follow-up appointmentCardiac rehabilitation start4–6 weeks postoperatively Standard postoperative care following cardiac surgery in Thorax Centrum Twente with lifestyle advice Sit up in a chair as soon as possible Get out of bed using the rope behind the bed and by shifting from side to side (waddling) Stand up by placing hands on the knees Asymmetrical arm movement without load is allowed Lying on the side: allowed if the drain is removed (and pain permits) Day 2: start walking Day 3: cycling (stationary bike) Before discharge: stair climbing, 11 or 22 steps However, there is limited evidence supporting standard postoperative sternal precautions [6]. Furthermore, to date, they have been framed negatively toward patients (“thou shall not”). The current sternal precautions may be too restrictive and based on insufficient evidence [7]. Adams et al. developed the concept of “Keep Your Move in the Tube” [7], as seen in Fig. 1. Several follow-up studies have successfully implemented these revised movement sternal precautions [8, 9]. The idea behind these precautions is to keep the upper arms close to the body, as if the patient is inside an imaginary tube with their upper body. This allows patients to safely perform weight-bearing movements while avoiding excessive strain on the sternum. Patients may lift, push, or pull as long as their arms remain within this “tube” (see Fig. 1). Previous studies have found no adverse effects when applying this guideline [7–9]. Specifically, no differences were found in the number of sternum-related complications between the control group and the intervention group, such as sternal refixation, superficial sternal wound infection, and deep sternal wound infection (DSWI) [9], as measured by the Sternal Instability Scale [10]. Additionally, an increase in upper body mobility was observed after 2–3 weeks post cardiac surgery [7]. A representation of the original “Keep Your Move in the Tube” diagram [7], where an imaginary tube surrounding the chest represents the boundary for the range of motion of the upper extremities (left panel). B Basic movements of the T-REX Twente sternal precautions inspired by Keep Your Move in the Tube However, another study found no significant difference in quality of life [9]. This finding may be attributed to the lack of a validated measurement instrument and a lack of post-hospitalization follow-up. Objectives {7} This study aims to determine whether the Thoracic Surgical Rehabilitation Experts (T-REX Twente) sternal precautions have a positive effect on the Modified MacNew Quality of Life after Myocardial Infarction questionnaire (QLMI-2) [11], physical activity, and reduction of movement-related anxiety in patients after full median sternotomy, compared to standard restrictive sternal precautions. It also assesses whether the T-REX sternal precautions result in no negative effects on pain, wound healing, or postoperative complications. We hypothesize that the T-REX Twente sternal precautions will have a small positive effect on quality of life, physical activity levels, and movement-related anxiety in cardiac patients following median sternotomy, compared to current restrictive sternal precautions. Trial design {8} The T-REX Twente trial is a prospective, randomized, single-blind study with two parallel groups. Allocation is by block randomization with a block of 4 in a 1:1 ratio. Primary endpoints will be assessed with a superiority design. An effect on at least one primary outcome is required to deem the study successful. Figure 2 is a flowchart for enrollment and analysis. Flowchart of T-REX Twente trial from enrollment to analysis Methods: participants, interventions, and outcomes Study setting {9} Thorax Centrum Twente (TCT) is situated in Medisch Spectrum Twente (MST), a non-academic teaching hospital in Enschede, the Netherlands (see Table 2). Patients are treated from referring hospitals throughout the northern and eastern part of the Netherlands. Only patients with a cardiologist from TCT will be screened for inclusion. A single-center design was chosen since cardiac rehabilitation in our center is conducted externally in collaboration with local physiotherapists, unlike other referring centers where it is provided in-hospital. Additionally, this study utilizes single patient rooms as is standard in our hospital, which serves as an additional requirement for choosing the single-blind study design. Table 2Summary table of expected demographic participant characteristics for the T-REX Twente protocolCharacteristicThe people we would expect to see includedAgeAverage age of patients receiving elective/urgent cardiac surgery is 68 years, with 38% being 18–64 years, 39% being 65–74 years, and 23% being 75 years or older [1] [https://www.hartenvaatcijfers.nl/analysetool/cardiochirurgie-cc4c2]SexAround 22% of elective/urgent cardiac surgery patients in the Netherlands receiving surgery between 2022 and 2024 have a female sex [https://www.hartenvaatcijfers.nl/analysetool/cardiochirurgie-cc4c2]GenderGender is not collected as part of the Netherlands Heart Registration (NHR) [12]. We expect this to follow the sex distribution [https://nhr.nl/handboeken/#handboeken]Race, ethnicity, and ancestryRace, ethnicity, and ancestry are not collected as part of the Netherlands Heart Registration [12]. These characteristics fall under special categories of personal data in the general data protection regulation (GDPR) and collection of these data are restricted [https://www.autoriteitpersoonsgegevens.nl/en/themes/basic-gdpr/privacy-and-personal-data/what-are-personal-data#special-categories-of-personal-data]For the Twente region in 2024, 11% of inhabitants were born outside of the Netherlands, while 10% have Asian (including the larger subgroups from Indonesia and Türkiye), 7.3% European (non-Dutch), and 1.5% African (including the larger subgroup ancestry from Morocco) [https://opendata.cbs.nl/#/CBS/nl/dataset/85458NED/table?dl=968B2]Socioeconomic statusSocioeconomic status is not collected as part of the Netherlands Heart Registration [12]. Socioeconomic status is considered sensitive personal data [https://www.autoriteitpersoonsgegevens.nl/en/themes/basic-gdpr/privacy-and-personal-data/what-are-personal-data#sensitive-personal-data]The Netherlands has one of the highest human development index of 0.955 in 2023 as stated by the United Nations Development Programme [https://hdr.undp.org/data-center/human-development-index#/indicies/HDI]. Twente has a lower socio-economic status than other parts in the Netherlands, where 20% have difficulty making ends meet [https://twentsekoers.nl/wp-content/uploads/2023/06/Basis-regiobeeld-Twente-2023.pdf]Geographic locationTwente is a rural area with urban centers in the eastern part of the Netherlands at the German border [https://kennis.cultureelerfgoed.nl/index.php/Panorama_Landschap_-_Twente]Table populated according to PRO-EDI recommendations for publishing in Trials [13] Summary table of expected demographic participant characteristics for the T-REX Twente protocol Race, ethnicity, and ancestry are not collected as part of the Netherlands Heart Registration [12]. These characteristics fall under special categories of personal data in the general data protection regulation (GDPR) and collection of these data are restricted [https://www.autoriteitpersoonsgegevens.nl/en/themes/basic-gdpr/privacy-and-personal-data/what-are-personal-data#special-categories-of-personal-data] For the Twente region in 2024, 11% of inhabitants were born outside of the Netherlands, while 10% have Asian (including the larger subgroups from Indonesia and Türkiye), 7.3% European (non-Dutch), and 1.5% African (including the larger subgroup ancestry from Morocco) [https://opendata.cbs.nl/#/CBS/nl/dataset/85458NED/table?dl=968B2] Socioeconomic status is not collected as part of the Netherlands Heart Registration [12]. Socioeconomic status is considered sensitive personal data [https://www.autoriteitpersoonsgegevens.nl/en/themes/basic-gdpr/privacy-and-personal-data/what-are-personal-data#sensitive-personal-data] The Netherlands has one of the highest human development index of 0.955 in 2023 as stated by the United Nations Development Programme [https://hdr.undp.org/data-center/human-development-index#/indicies/HDI]. Twente has a lower socio-economic status than other parts in the Netherlands, where 20% have difficulty making ends meet [https://twentsekoers.nl/wp-content/uploads/2023/06/Basis-regiobeeld-Twente-2023.pdf] Table populated according to PRO-EDI recommendations for publishing in Trials [13] Eligibility criteria {10} Inclusion criteria Patients ≥18 years Patients ≥18 years Patients who undergo cardiac surgery via median sternotomy Patients who undergo cardiac surgery via median sternotomy Patients who are treated by their cardiologist at Medisch Spectrum Twente Patients who are treated by their cardiologist at Medisch Spectrum Twente Exclusion criteria Post-operative intensive care unit (ICU) stay >72 h Post-operative intensive care unit (ICU) stay >72 h Postoperative delirium according to Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) or dementia (or other significant cognitive impairments) Postoperative delirium according to Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5) or dementia (or other significant cognitive impairments) Dutch language barrier Dutch language barrier Cardiologist located outside of Medisch Spectrum Twente Cardiologist located outside of Medisch Spectrum Twente Participants who remain in the ICU over 72 h will be excluded. These participants typically experience a more complicated post-operative recovery and will likely require a longer mobilization trajectory. Given the relatively small patient population, this could significantly impact the study results. Who will take informed consent? {26a} A physiotherapist informs the patient about the study at the preoperative outpatient ward. After being informed about the study, patients receive the information brochure with informed consent form to consider. When interested, informed consent is subsequently signed on the day of admission for surgery. In the case of an “urgent” clinical admission, i.e., needing surgery within the same hospital admission [14], the patient is informed about the study a few days prior to surgery. Additional consent provisions for collection and use of participant data and biological specimens {26b} Additional consent provisions are required for the collection and use of participant data. This pertains to the retrieval of information from the general practitioner/specialist(s) who treats participants regarding new contact details and/or medical history, to store and use for future research on conditions and/or the treatment method being studied, and if participants want to be contacted for follow-up research after the study. No biological specimens will be obtained for this study. Interventions Explanation for the choice of comparators {6b} Mobilization guidelines applied to the control group consist of standard guidelines and recommendations currently provided to participants (usual care). Contrarily, the intervention group receives mobilization recommendations based on KYMITT principles and were altered for our study into the T-REX Twente sternal precautions. Intervention description {11a} The standard mobilization intervention for all participants begins in the ICU, followed by continuation on the general ward, and generally includes the following as previously described [15]: Day 1: Breathing exercises, coughing techniques, mobility assessment of arms and legs, transfer from bed to chair with assistance; possible walking to the bathroom (Borg Rating of Perceived Exertion Scale 7–9). Day 1: Breathing exercises, coughing techniques, mobility assessment of arms and legs, transfer from bed to chair with assistance; possible walking to the bathroom (Borg Rating of Perceived Exertion Scale 7–9). Day 2: Exercises as on day 1. Working towards participant independence. Self-transfer from bed to chair with or without assistance, and if possible, walking with or without walking aids in the room/ward (±10–30 m); if safe, repeat independently (Borg scale 7–9). Day 2: Exercises as on day 1. Working towards participant independence. Self-transfer from bed to chair with or without assistance, and if possible, walking with or without walking aids in the room/ward (±10–30 m); if safe, repeat independently (Borg scale 7–9). Day 3: Exercises as on day 2. Independent walking extended, with increased distance (±10–100 m) and frequency (3–6 times), 5–15 min of cycling at 5–25 W (low resistance, Borg scale 9–11) depending on the patient’s condition. Day 3: Exercises as on day 2. Independent walking extended, with increased distance (±10–100 m) and frequency (3–6 times), 5–15 min of cycling at 5–25 W (low resistance, Borg scale 9–11) depending on the patient’s condition. Day 4: Exercises as on day 3. Stair climbing (11 or 22 steps) with assistance, information on home mobilization and if possible, increasing the duration (10–20 min) and resistance (15–25 W) on the stationary bike (Borg scale 11). Day 4: Exercises as on day 3. Stair climbing (11 or 22 steps) with assistance, information on home mobilization and if possible, increasing the duration (10–20 min) and resistance (15–25 W) on the stationary bike (Borg scale 11). Post-operative mobilization and protective sternal precautions consist of regular instructions for all groups (Table 3) and trial arm specific instructions (Table 4). Table 3Postoperative mobilization guidelines and sternal precautions for both groupsControl and intervention groupsCoughing/sneezingProtect wound by crossing arms on chestSleeping in bedIf drain is removed, lie/sleep on the sideGrabbing items without forceIt is okay to grab your wallet from your back pocketCycling and driving2–3 weeks postoperatively after first follow-up appointment, provided the wound appears to be healing wellCardiac rehabilitationStarts 4–6 weeks postoperatively Postoperative mobilization guidelines and sternal precautions for both groups Table 4Postoperative mobilization guidelines and sternal precautions following total median sternotomy, specific for trial armsPostoperative activityControl groupIntervention group (T-REX Twente sternal precautions)Getting up in bedUsing the drawstringaUsing the drawstring or via lying on the side with elbows at the sideGetting up from the edge of the bed or chairHands positioned on the kneesWith elbows at the side, push off the bed and/or chair. Pushing with arms is allowedMoving in bedWaddle forwardMay use hands as in “T-REX Twente” sternal precautionsWalking with crutches or caneNot allowed in the first 4 weeks due to asymmetric sternal loadAllowed if the participant can keep elbows at the side and experiences no increase in painOpening doorsNot more than 2 kg and symmetrically in the first 6 weeksUsing “T-REX Twente” sternal precautionsPushing, lifting, or pullingNot more than 2 kg and symmetrically in the first 6 weeksUsing “T-REX Twente” sternal precautionsHousehold tasksOnly light tasksAllowed if pain permits; mowing the lawn, taking out the trash, and vacuuming are acceptable if the arms can be kept at the side while exerting forceaA rope or cord attached to the hospital bed, enabling the participant to pull themselves up to a sitting position“T-REX Twente” sternal precautions (Fig. 1) indicate that when participants keep their elbows at their sides, they are allowed to push, lift, and pull based on pain tolerance. If this does not cause (sudden) pain increases, the patient may progressively increase load outside this imaginary cylinder Postoperative mobilization guidelines and sternal precautions following total median sternotomy, specific for trial arms aA rope or cord attached to the hospital bed, enabling the participant to pull themselves up to a sitting position “T-REX Twente” sternal precautions (Fig. 1) indicate that when participants keep their elbows at their sides, they are allowed to push, lift, and pull based on pain tolerance. If this does not cause (sudden) pain increases, the patient may progressively increase load outside this imaginary cylinder Over a period of approximately 12 weeks, all participants will complete the three questionnaires QLMI-2, Tampa Scale for Kinesiophobia (TSK-17), and Numeric Pain Rating Scale (NPRS) at four time points: preoperatively (T0), on the 4th post-operative day (T2), on the first day of cardiac rehabilitation (4–6 weeks, T4), and on the last day of cardiac rehabilitation (10–12 weeks) (T5). Completing these questionnaires will take approximately 15 min per session. All measurements will take place during routine appointments at the hospital and as part of the outpatient cardiac rehabilitation at the location where the participant is training. Additionally, two AX3 accelerometers will be placed, on the upper arm and upper thigh using Tegaderm patches (details: see Halfwerk et al. [16]) on the first post-operative day. These AX3 accelerometers will measure the level of movement starting from day 1 postoperatively up to a maximum of 7 days (or earlier when discharged at T1, T2, and T3). Participants have previously indicated that they did not find the AX3 accelerometers burdensome, restrictive, or uncomfortable [16]. Criteria for discontinuing or modifying allocated interventions {11b} Participants may withdraw from the study at any time. This decision will have no consequences for their medical care. The investigator may also decide to withdraw a subject from the study for urgent medical reasons. Specific criteria for discontinuation of the study for an individual participant include severe sternal complications, such as recurrent DSWI or the need for sternal refixation. Available data will be handled as an intention-to-treat analysis. Strategies to improve adherence to interventions {11c} The primary strategy to ensure sustained implementation of the intervention is to actively inform all relevant healthcare professionals when a T-REX participant is admitted to the clinic or enrolled in cardiac rehabilitation. Relevant concomitant care permitted or prohibited during the trial {11d} Concomitant care and interventions are described in Tables 3 and 4. Sternal pain between hospital discharge (T3) and end of cardiac rehabilitation (T5) may be treated according to the physician’s discretion. We do not prohibit any type of care in any of our trial arms. Provisions for post-trial care {30} The investigator has liability insurance which is in accordance with Article 7 of the Dutch Medical Research Involving Human Subjects Act (WMO). The sponsor (also) has an insurance which is in accordance with the legal requirements in the Netherlands (Article 7 WMO). This insurance provides cover for damage to research subjects through injury or death caused by the study. The insurance applies to the damage that becomes apparent during the study or within 4 years after the end of the study. Outcomes {12} Primary outcomes The first primary outcome is to evaluate whether the T-REX Twente sternal precautions (Fig. 1), in comparison to the standard sternal precautions used in TCT, have an effect on the quality of life (QLMI-2) of participants following a median sternotomy, from preoperative (T0) to the start of cardiac rehabilitation 4–6 weeks postoperatively (T4). The second primary objective is to assess the level of participant mobilization as the relative proportion of time spent out of bed during the day, measured by an AX3 accelerometer (Axivity, Newcastle upon Tyne, UK) until the 4th post-operative day (T2). The participant pathway with all measurements is described in Fig. 3. The “typical patient journey” with time points (T-points) and actions. OR = operating room, IC = informed consent, ICU = intensive care unit, QLMI-2 = Modified Quality of Life after Myocardial Infarction questionnaire, NPRS = Numeric Pain Rating Scale Secondary outcomes A secondary outcome of the study is to determine whether the T-REX Twente sternal precautions affect pain, as measured by the Numeric Pain Rating Scale during T0, T2, T4, and at the end of the cardiac rehabilitation (T5) (NPRS). Furthermore, the study aims to investigate whether the T-REX Twente sternal precautions have an effect on the degree of movement-related fear, as measured by the Tampa Scale for Kinesiophobia, during T0 (preoperatively), T2, T4, and at the end of cardiac rehabilitation (T5). Another secondary objective is to assess the effect of the T-REX Twente sternal precautions on both the number of minutes per day and the relative proportion of time spent on individual activities (lying in bed, sitting, standing, walking, cycling, stair climbing) during daytime (7:00–23:00) as measured by the AX3 accelerometers [16]. We measured from the 1 st day postoperative (T1) until discharge or up to a maximum of 7 days post-heart surgery (T3) in line with previous work [16]. Additionally, the study aims to investigate whether the T-REX Twente sternal precautions are associated with a higher incidence of sternal complications within 30 days, using a composite endpoint of sternal refixation, superficial sternal wound infection, and deep sternal wound infection (DSWI). The hypothesis is that participants will resume activities of daily living more quickly and experience less anxiety, as they are able to do more and are allowed to engage in more activities. Participant timeline {13} Patient contact moments are aligned with the times when the patient is clinically admitted or has outpatient appointments. Figure 4 provides a schematic overview of all contact moments throughout the study. Schedule of enrollment, interventions (blue), and assessment during the T-REX Twente trial. Formatted according to SPIRIT recommendations [17]. Primary endpoints and timeframe indicated in green, secondary endpoints in vermillion Randomization is conducted using CS-Research HiX 6.3 (Healthcare Information eXchange, Chipsoft, Amsterdam, the Netherlands), with a primary focus on the interaction between the group (intervention versus control) and time. Sample size {14} The primary outcome of this study is QLMI-2, the validated Dutch translation of the MacNew questionnaire [11]. Previous research using the QLMI-2 in a cohort of 677 cardiac rehabilitation patients indicated that the difference in response scores is normally distributed, with a standard deviation of 0.25 [18]. Another study showed an increase in QLMI-2 scores from 5.2 to 6.1 between hospital discharge (comparable to T3 in our study) and the intake for cardiac rehabilitation (comparable to T4 in our study), reflecting a change of 0.9 [19]. Assuming a small effect size of 0.15 (Cohen’s d [20]) and a statistical power of 80%, a total of 138 participants are required (69 per group) to detect a group*time interaction across three measurement points (T0, T2, and T4). The effect size is based on the expectation that the adapted lifestyle sternal precautions will not result in large differences. As this is a minimal, non-costly intervention, even a small effect can be considered clinically relevant. This calculation is based on repeated ANOVA measures with an alpha of 0.05, power of 0.80, and a nonsphericity correction of 1, computed using G*Power 3.1.9.7. To account for an estimated 10% dropout rate, we plan to include 77 participants per group, resulting in a total sample size of 154 participants. The anticipated 10% dropout is based on participants who may die as a result of surgery, miss assessments due to post-operative delirium, or experience an extended ICU stay exceeding 72 h. The 30-day mortality rate is approximately 1.3%, and about 10% of participants experience prolonged ICU stays. This results in a total sample size of 154 participants, after appropriate rounding. Recruitment {15} Assignment of interventions: allocation Patients will only be asked to participate in the study by a physiotherapist during preoperative hospital stay (urgent surgery) or during preoperative outpatient screening (elective surgery) (see section 26a). Sequence generation {16a} Randomization is generated through CS-Research HiX 6.3, a digital randomization system, where data are pre-entered to ensure equivalent distribution between the two groups. Participants are randomly allocated to control and intervention groups in a 1:1 ratio with a block size of 4. The researcher informs the healthcare professionals of the patient’s group allocation, enabling them to apply the appropriate intervention. Additionally, the researcher ensures that accelerometers and questionnaires are provided to the patient. Concealment mechanism {16b} Randomization is performed digitally using CS-Research HiX 6.3 after the patient has provided written informed consent. Until surgery, only authorized staff members have access to the patient’s group allocation. The rest of the study personnel remain blinded to this information until postoperative. Blinding is only possible for the participant and the assessor of outcomes, as the staff needs to know the assigned treatment in order to provide appropriate care. This results in a single-blind design where participants and outcome assessors are blinded. Implementation {16c} During the preoperative outpatient screening, the physiotherapist discusses the patient’s potential interest in the study, provides the participant information sheet, informed consent form, and questionnaires, and addresses any questions the patient may have. In cases of an “urgent” clinical admission [14], the patient is informed about the study a few days prior to surgery. If interested, the researcher or delegated physiotherapist is notified, after which further information is provided, and consent is requested. Access to source data and any other patient-identifiable information is restricted to the researchers KR and NW, as well as the principal investigator, FH. All study data are coded and accessible only to the researchers. The coding consists of a unique identifier, for example, H24-005-001. Assignment of interventions: blinding Who will be blinded {17a} Due to the study design, physiotherapists, nurses, and other healthcare professionals cannot be blinded. The participant will be blinded; however, it is possible that they may deduce their group assignment based on the instructions or through conversations with other patients. The investigator (FH) is responsible for the analysis and will therefore be blinded for group assignment. Procedure for unblinding {17b} The professionals involved in patient care are not blinded, which means that if the intervention arm of the study should be discontinued, this can be done without obstructions. Only if a significant difference is found in sternal complications after 30 days during the interim analysis, to the disadvantage of the T-REX Twente intervention arm, will FH, who conducts the analysis and is unaware of the group assignments (control or intervention), be fully unblinded. Data collection and management Plans for assessment and collection of outcomes {18a} Over a period of approximately 12 weeks, participants will complete the three questionnaires QLMI-2, TSK, and NPRS at the following time points: preoperatively (T0), post-operative day 4 (T2), on the first day of cardiac rehabilitation (T4, approximately 4–6 weeks post-operative), and on the final day of cardiac rehabilitation (T5, approximately 10–12 weeks post-operative). Completing the questionnaires will take approximately 15 min per time. Questionnaire descriptions with reliability and validity are available elsewhere (www.meetinstrumentenindezorg.nl). All assessments will take place during routine clinical appointments at MST and during outpatient cardiac rehabilitation sessions at the location where the participant is enrolled. Questionnaires will be securely stored and documented in the electronic health records, which will also be used to manage the timeline and study phases. Additionally, two AX3 accelerometers will be applied on the upper arm and upper leg (see [16]) by either a nurse or physiotherapist on post-operative day 1. These AX3 accelerometers will monitor physical activity levels continuously from post-operative day 1 for a period of up to 7 days (or until discharge, if earlier) at T1, T2, and T3. Plans to promote participant retention and complete follow-up {18b} Contact with patients is initiated during their designated hospital visiting hours and throughout their participation in the cardiac rehabilitation program. A structured logbook is maintained throughout the study to document all participating participants by their anonymized patient number, in conjunction with the date of surgery and all relevant measurement time points. Upon inclusion in the study, patients’ data are recorded in the logbook, facilitating systematic tracking of the total number of enrolled participants, those who have commenced the study protocol, and those who have completed all scheduled assessments. In cases where participants discontinue participation, data collected up to the point of withdrawal will still be included in the final analysis. An additional follow-up strategy involves scheduling appointments to contact participants by telephone or email, specifically to encourage completion of the questionnaires corresponding to measurement of time points T4 and T5. These questionnaires are then provided either digitally or via postal mail, accompanied by a return envelope to facilitate their return. Data management {19} All data pertaining to study participants are collected, stored, and managed exclusively by trained study personnel and research assistants. Physical documents, including signed informed consent forms and paper-based questionnaires, are immediately filed in a secure folder stored behind locked doors. Access to these physical records is restricted to research assistants and researchers. Digital copies of the informed consent forms and completed questionnaires are stored in a secure Microsoft Teams environment, accessible only to authorized research personnel. In addition, questionnaire data are entered into a pre-configured list within the HiX system (HiX Research module). Subsequently, data from HiX Research are exported by the research team to an SPSS or Excel file on a local, encrypted hard drive. This file is coded and anonymized, with the code key accessible only to the principal investigators and designated research assistants. The hard drive is stored in a locked cabinet, access to which is restricted solely to the research team. All data processing and analysis are conducted on coded and de-identified datasets within the MST infrastructure, ensuring compliance with institutional and data protection regulations. Confidentiality {27} Participants’ individual study information will not be shared without written permission of the participant, except for mandatory study monitoring and safety purposes. See the “Data management {19}” section for details on storage and handling. Biological specimens {33} Not applicable. Statistical methods Statistical methods for primary and secondary outcomes {20a} Time points and variable information were previously described in Fig. 4. Statistical analysis will be performed using repeated measures of analysis within a mixed model framework, employing SPSS software (IBM Corp., Armonk, NY). The primary focus will be on the interaction effect between group allocation (intervention versus control) and time. A p value < 0.05 will be considered indicative of statistical significance. For the second primary outcome, the relative percentage of time spent out of bed during daytime hours (defined as 06:00–23:00) will be assessed using two AX3 accelerometers [16], applied during the intensive care unit (ICU) stay and continued on the general ward until post-operative day 4. Previous studies have demonstrated that, on the first day following ICU discharge, patients spend approximately 60% of the daytime lying down, with a daily decrease of 6.5% (p < 0.001) [16]. Interim analyses {21b} An interim analysis for safety will be conducted once 30 participants have been included in each group. If this interim analysis shows that the intervention group has 3 more patients reaching the combined endpoint than the control group, the study will be stopped. Public outcomes from the Netherlands Heart Registration (2020–2024) for the combined endpoint of sternal wound complications were 1.3% in MST and 0.8% in NL (range 0.4–1.8%) [1]. A higher interim analysis threshold has been chosen due to the small number of patients included, which may present a distorted picture. Methods for additional analyses (e.g., subgroup analyses) {20b} Netherlands Heart Registration (NHR) variables [12] will be analyzed in the same manner as the secondary outcomes. Normally distributed baseline variables will be analyzed using an unpaired Student’s t-test, or Mann-Whitney U test if non-parametric. Categorical variables will be analyzed using Fisher’s exact test. Methods in analysis to handle protocol non-adherence and any statistical methods to handle missing data {20c} Continuous variables over time, such as QLMI-2 and TSK questionnaires, and NPRS changing over the 4 phases, will be analyzed via a mixed model repeated measurement analysis. The advantage of this model is that incidental missing data can be estimated by patterns of other participants. No data will be imputed. Plans to give access to the full protocol, participant-level data, and statistical code {31c} We are exploring the possibility of publishing the anonymized data under open access in accordance with FAIR principles in the 4TU.ResearchData repository. Oversight and monitoring Composition of the coordinating center and trial steering committee {5d} The day-to-day conduct of the trial is overseen by the PI in collaboration with the research assistants. Regular team meetings are held on a weekly basis between the PI and research assistants to monitor study progress and coordinate ongoing activities. Each week, the research assistants update the study team regarding participants scheduled for surgery or commencing cardiac rehabilitation. This ensures timely attention to data collection and management procedures at the relevant measurement time points. Composition of the data monitoring committee, its role and reporting structure {21a} MST adheres to the Dutch Federation of University Medical Centers (NFU) “Monitoring” guideline. Specific information is outlined in the monitoring plan, dated/versioned (27-09−2023/2.3). This study includes an institutional monitoring advisor responsible for overseeing participant safety. After the first five participants are enrolled in both the control and intervention groups, the monitoring advisor will assess participant safety. Monitoring visits will occur multiple times throughout the study (approximately 2 to 4 times) to ensure continued participant safety. Adverse event reporting and harms {22} No study-related adverse events (AEs) or serious adverse events (SAEs) are anticipated, given the minimal-risk nature of the intervention. The potential risks associated with the intervention have been previously assessed in KYMITT studies [7, 8]. Passive safety monitoring will be conducted by the research staff throughout the study. Any observed or reported AEs or SAEs will be communicated to the PI, who holds responsibility for reporting them in accordance with the applicable regulations to the Central Committee on Research Involving Human Subjects (CCMO). All adverse events will be recorded in HiX and, if necessary, will be discussed with the research team, TCT management, and an epidemiologist from MST. In the publication of the trial results, the total number of reported AEs and SAEs will be included to ensure full transparency regarding the safety profile of the intervention. Frequency and plans for auditing trial conduct {23} In case of significant errors or concerns regarding safety, monitoring of the relevant area will be increased as deemed reasonable, in consultation with institutional monitors. For source data verification, at least 1 participant will be monitored for 100% on all data collected. Initiation visits with monitors are conducted before study starts, and 1 to 2 times per year (see Table 5). The frequency may be adjusted during the study if desired. Table 5T-REX Twente trial audit and monitoring overviewComponentPercentageNumber of study participantsInformed consentMin. 10%154 participantsInclusion and exclusion criteria1–2.5%2–5Source data verification1–2.5%2–5Serious adverse events (SAEs) and suspected unexpected serious adverse reactions (SUSARs)7.5%Unforeseen T-REX Twente trial audit and monitoring overview Plans for communicating important protocol amendments to relevant parties (e.g., trial participants, ethical committees) {25} Any substantial amendments to the study protocol will be promptly reported to all relevant stakeholders. These include the CCMO, co-investigators, study personnel, involved medical staff of TCT, and hospital board of MST. Dissemination plans {31a} The trial information and protocol are registered in the CCMO registry (formerly Dutch Trial Register, www.onderzoekmetmensen.nl/en/trial/56700). The study will be submitted for peer-reviewed open access publication in a relevant journal, such as Annals of Thoracic Surgery, Healthcare (Switzerland), or Clinical Rehabilitation. The results will also be shared with colleagues at scientific conferences, including the Dutch Physiotherapy Conference, the MST Symposium, and SCTS annual meeting. Discussion Throughout the course of the study, there has been an increase in the number of open-heart surgeries performed using a minimally invasive approach. Because a mini-sternotomy or transaxillary access route might affect the studied protocol, we decided not to increase our inclusion criteria. As a result, we may experience delays in the inclusion of participants for the study. However, findings from this research could provide valuable insights for the physiotherapeutic approach to this patient population as well. Limitations One of our exclusion criteria is patients who remain in the ICU for more than 72 h. These patients typically represent a more vulnerable subgroup with increased morbidity and mortality, and delayed mobilization. Excluding this population may limit the representativeness of our study population to clinical practice. Other centers have incorporated an all-comer approach for less restrictive sternal precautions [8], and may be applied to all cardiac surgery populations regardless of ICU stay or access route like minimally invasive surgery. Next, a single-center design may restrict the external validity of the findings. Patients were randomized to limit selection bias, yet results may reflect institutional protocols, or clinical expertise of one hospital. Trial status The current version of the T-REX Twente study protocol is version 8.4, dated February 22, 2024. Participant recruitment for the T-REX Twente study commenced on May 21, 2024. Recruitment is expected to be completed by March 2026. Supplementary Information Additional file 1. Acknowledgements The authors acknowledge the contribution of Karen Wiens and Jodi Koch (Alberta Health Services, Canada) for their valuable feedback on this study protocol manuscript. The authors wish to express their gratitude to Peter Halfwerk-Hagel for coming up with the T-REX Twente trial acronym. Abbreviations Accelerometer sensor from Axivity Ltd, Newcastle upon Tyne, UK Central Committee on Research Involving Human Subjects; in Dutch: Centrale Commissie Mensgebonden Onderzoek Diagnostic and Statistical Manual of Mental Disorders 5th edition Deep sternal wound infection General Data Protection Regulation; in Dutch: Algemene Verordening Gegevensbescherming (AVG) Healthcare Information eXchange Cardiac Rehabilitation and Prevention East Netherlands Foundation, in Dutch: Stichting Hartrevalidatie en Preventie Oost Nederland Informed consent Intraclass correlation coefficient Intensive care unit Keep Your Move in the Tube Medical research ethics committee (MREC); in Dutch: medisch-ethische toetsingscommissie (METC) Medisch Spectrum Twente hospital Dutch Federation of University Medical Centers; in Dutch: Nederlandse Federatie van Universitair Medische Centra Netherlands Heart Registration Numeric Pain Rating Scale, average pain in the past 3 days Operating room Principal investigator Modified MacNew Quality of Life after Myocardial Infarction questionnaire (Serious) adverse event Society for Cardiothoracic Surgery in Great Britain and Ireland Standard Protocol Items: Recommendations for Interventional Trials Statistical Package for the Social Sciences Suspected unexpected serious adverse reaction Thorax Centrum Twente Thoracic Surgical Rehabilitation Experts Twente; in Dutch: Thoraxchirurgische Revalidatie Experts Twente Tampa Scale of Kinesiophobia, a 17-item self-report checklist Medical Research Involving Human Subjects Act; in Dutch: Wet Medisch-wetenschappelijk Onderzoek met Mensen Authors’ contributions {31b} Conceptualization: NW, KR, LE, FH; methodology: JvdP and FH; validation: JvdP and FH; formal analysis: JvdP and FH; investigation: NW and KR; resources: LE, WL, JvdP, FH; writing—original draft: NW, KR, FH; writing—review and editing: NW, KR, LE, WL, JvdP, FH; visualization: KR and FH; supervision: WL, JvdP, FH; project administration: NW and FH; funding acquisition: NW and FH. Authors’ information KR and NW are experienced physical therapists at TCT. NW applied early mobilization activities since her leadership program in 2016. WL is a cardio-thoracic surgeon, surgical ward manager, and member of the TCT board during the study. JvdP is a clinical epidemiologist at MST and professor at Section Cognition, Data and Education (CODE) of the University of Twente. LE is a physical therapist and leads the KYMITT implementation at Foothills Medical Center. FH is a technical medical doctor in cardio-thoracic surgery and involved in early mobilization after cardiac surgery since 2016, and holds a joint position as associate professor at the University of Twente where he leads the Cardiac Surgery Innovations Lab. Funding {4} NW’s research time was funded by HPON Foundation. Additionally, accelerometers used in the study were partially sponsored by the Heart Center Twente Foundation for the MOVEMENTT study [16], which was previously conducted in Thorax Centrum Twente. Data availability {29} The trial information and protocol are registered in the CCMO register (formerly Dutch Trial Register). Data may become openly available in a public repository and/or may be available on request to the corresponding author. Declarations Ethics approval and consent to participate {24} This trial has been approved by the competent authority, Medical Research Ethics Committees United (MEC-U R23.091), ensuring scientific integrity and compliance with applicable research regulations and ethical standards for the protection of human participants. In addition, approval has been granted by the sponsor, the local Medical Ethics Committee of Medisch Spectrum Twente, on 24 April 2024 (MST, H24-005). Written, informed consent to participate will be obtained from all participants. Consent for publication {32} Participants gave consent for data collection and dissemination. We have included the Dutch informed consent form with this submission (see Additional file 1). Competing interests {28} The authors declare that they have no competing interests for this submission. Footnotes Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. References Associated Data Supplementary Materials Additional file 1. Data Availability Statement The trial information and protocol are registered in the CCMO register (formerly Dutch Trial Register). Data may become openly available in a public repository and/or may be available on request to the corresponding author.